Cargando…
Long-term Safety and Tolerability of Omadacycline for the Treatment of Mycobacterium abscessus Infections
BACKGROUND: Mycobacterium abscessus is a virulent human pathogen. Treatment is complex and often poorly tolerated with suboptimal rates of eradication, highlighting the need for improved therapeutics. This study reports clinical experience with omadacycline for treatment of M abscessus infections at...
Autores principales: | Mingora, Christina M, Bullington, Wendy, Faasuamalie, Paige E, Levin, Adrah, Porter, Gabriella, Stadnik, Ryan, Varley, Cara D, Addrizzo-Harris, Doreen, Daley, Charles L, Olivier, Kenneth N, Winthrop, Kevin L, Dorman, Susan E, Flume, Patrick A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10354853/ https://www.ncbi.nlm.nih.gov/pubmed/37476076 http://dx.doi.org/10.1093/ofid/ofad335 |
Ejemplares similares
-
Omadacycline for the Treatment of Mycobacterium abscessus Disease: A Case Series
por: Pearson, Jeffrey C, et al.
Publicado: (2020) -
Omadacycline Potentiates Clarithromycin Activity Against Mycobacterium abscessus
por: Bich Hanh, Bui Thi, et al.
Publicado: (2021) -
Omadacycline as a promising new agent for the treatment of infections with Mycobacterium abscessus
por: Bax, Hannelore I, et al.
Publicado: (2019) -
Preliminary, Real-world, Multicenter Experience With Omadacycline for Mycobacterium abscessus Infections
por: Morrisette, Taylor, et al.
Publicado: (2021) -
Omadacycline for the treatment of Mycobacterium abscessus infections: Case series and review of the literature
por: Siddiqa, Ayesha, et al.
Publicado: (2023)